| Whole-exome sequencing of metastatic cancer and biomarkers of treatment response H Beltran, K Eng, JM Mosquera, A Sigaras, A Romanel, H Rennert, ... JAMA oncology 1 (4), 466-474, 2015 | 307 | 2015 |
| Genetic risk assessment in carrier testing for spinal muscular atrophy S Ogino, DGB Leonard, H Rennert, WJ Ewens, RB Wilson American journal of medical genetics 110 (4), 301-307, 2002 | 233 | 2002 |
| Clinical, pathologic, and molecular features of early-onset colorectal carcinoma RK Yantiss, M Goodarzi, XK Zhou, H Rennert, EC Pirog, BF Banner, ... The American journal of surgical pathology 33 (4), 572-582, 2009 | 221 | 2009 |
| A novel founder mutation in the RNASEL gene, 471delAAAG, is associated with prostate cancer in Ashkenazi Jews H Rennert, D Bercovich, A Hubert, D Abeliovich, U Rozovsky, A Bar-Shira, ... The American Journal of Human Genetics 71 (4), 981-984, 2002 | 164 | 2002 |
| Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma F Bao, NC Panarelli, H Rennert, DL Sherr, RK Yantiss The American journal of surgical pathology 34 (12), 1798-1804, 2010 | 152 | 2010 |
| Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions D Butler, C Mozsary, C Meydan, J Foox, J Rosiene, A Shaiber, D Danko, ... Nature communications 12 (1), 1660, 2021 | 144 | 2021 |
| Early introductions and transmission of SARS-CoV-2 variant B. 1.1. 7 in the United States T Alpert, AF Brito, E Lasek-Nesselquist, J Rothman, AL Valesano, ... Cell 184 (10), 2595-2604. e13, 2021 | 135 | 2021 |
| Urine microRNA as potential biomarkers of autosomal dominant polycystic kidney disease progression: description of miRNA profiles at baseline IZ Ben-Dov, YC Tan, P Morozov, PD Wilson, H Rennert, JD Blumenfeld, ... PloS one 9 (1), e86856, 2014 | 116 | 2014 |
| Association of Susceptibility Alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with Prostate Cancer Severity in European American and African American Men H Rennert, CM Zeigler-Johnson, K Addya, MJ Finley, AH Walker, ... Cancer Epidemiology Biomarkers & Prevention 14 (4), 949-957, 2005 | 115 | 2005 |
| The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations L Huang, H Fernandes, H Zia, P Tavassoli, H Rennert, D Pisapia, ... Journal of the American Medical Informatics Association 24 (3), 513-519, 2017 | 114 | 2017 |
| Evaluation of prostate cancer characteristics in four populations worldwide CM Zeigler-Johnson, H Rennert, RD Mittal, M Jalloh, R Sachdeva, ... The Canadian journal of urology 15 (3), 4056, 2008 | 109 | 2008 |
| Clinical performance of SARS-CoV-2 molecular tests DA Green, J Zucker, LF Westblade, S Whittier, H Rennert, P Velu, ... Journal of clinical microbiology 58 (8), 10.1128/jcm. 00995-20, 2020 | 97 | 2020 |
| Autosomal dominant polycystic kidney disease: genetics, mutations and microRNAs YC Tan, J Blumenfeld, H Rennert Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (10 …, 2011 | 93 | 2011 |
| Sterol carrier protein 2: a role in steroid hormone synthesis? SM Pfeifer, EE Furth, T Ohba, YJ Chang, H Rennert, N Sakuragi, ... The Journal of steroid biochemistry and molecular biology 47 (1-6), 167-172, 1993 | 90 | 1993 |
| The structure of the human sterol carrier protein X/sterol carrier protein 2 gene (SCP2) T Ohba, H Rennert, SM Pfeifer, Z He, R Yamamoto, JA Holt, JT Billheimer, ... Genomics 24 (2), 370-374, 1994 | 85 | 1994 |
| Shotgun transcriptome and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions DJ Butler, C Mozsary, C Meydan, D Danko, J Foox, J Rosiene, A Shaiber, ... BioRxiv, 2020 | 83 | 2020 |
| Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care H Rennert, K Eng, T Zhang, A Tan, J Xiang, A Romanel, R Kim, W Tam, ... NPJ genomic medicine 1 (1), 1-11, 2016 | 79 | 2016 |
| Molecular diagnosis of autosomal dominant polycystic kidney disease using next-generation sequencing AY Tan, A Michaeel, G Liu, O Elemento, J Blumenfeld, S Donahue, ... The Journal of Molecular Diagnostics 16 (2), 216-228, 2014 | 75 | 2014 |
| Novel method for genomic analysis of PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease YC Tan, JD Blumenfeld, R Anghel, S Donahue, R Belenkaya, M Balina, ... Human mutation 30 (2), 264-273, 2009 | 75 | 2009 |
| Duplications and de novo deletions of the SMNt gene demonstrated by fluorescence‐based carrier testing for spinal muscular atrophy KL Chen, YL Wang, H Rennert, I Joshi, JK Mills, DGB Leonard, RB Wilson American journal of medical genetics 85 (5), 463-469, 1999 | 75 | 1999 |